These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 8833170)
1. Injective versus sublingual immunotherapy in Alternaria tenuis allergic patients. Bernardis P; Agnoletto M; Puccinelli P; Parmiani S; Pozzan M J Investig Allergol Clin Immunol; 1996; 6(1):55-62. PubMed ID: 8833170 [TBL] [Abstract][Full Text] [Related]
2. Sublingual versus injective immunotherapy in grass pollen allergic patients: a double blind (double dummy) study. Quirino T; Iemoli E; Siciliani E; Parmiani S; Milazzo F Clin Exp Allergy; 1996 Nov; 26(11):1253-61. PubMed ID: 8955574 [TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of various methods of diagnosing hypersensitivity to Alternaria. Escudero AI; Sánchez-Guerrero IM; Mora AM; Soriano V; López JD; García FJ; Negro JM; Hernández J; Pagán JA Allergol Immunopathol (Madr); 1993; 21(4):153-7. PubMed ID: 8237720 [TBL] [Abstract][Full Text] [Related]
4. Effects of sublingual immunotherapy in patients sensitised to Ambrosia. An open controlled study. Valle C; Bazzi S; Berra D; Sillano V; Puccinelli P; Parmiani S Allergol Immunopathol (Madr); 2000; 28(6):311-7. PubMed ID: 11269898 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of sublingual swallow immunotherapy in children with severe grass pollen allergic symptoms: a double-blind placebo-controlled study. Bufe A; Ziegler-Kirbach E; Stoeckmann E; Heidemann P; Gehlhar K; Holland-Letz T; Braun W Allergy; 2004 May; 59(5):498-504. PubMed ID: 15080830 [TBL] [Abstract][Full Text] [Related]
6. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. Horst M; Hejjaoui A; Horst V; Michel FB; Bousquet J J Allergy Clin Immunol; 1990 Feb; 85(2):460-72. PubMed ID: 2406323 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of sublingual specific immunotherapy in patients with respiratory allergy to Alternaria alternata: a randomised, assessor-blinded, patient-reported outcome, controlled 3-year trial. Pozzan M; Milani M Curr Med Res Opin; 2010 Dec; 26(12):2801-6. PubMed ID: 21050060 [TBL] [Abstract][Full Text] [Related]
8. [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis]. Zhu L; Zhu LP; Chen RX; Tao QL; Lu JH; Cheng L Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):986-91. PubMed ID: 22336009 [TBL] [Abstract][Full Text] [Related]
9. Sublingual immunotherapy with a latex extract in paediatric patients: a double-blind, placebo-controlled study. Bernardini R; Campodonico P; Burastero S; Azzari C; Novembre E; Pucci N; Massai C; De Martino M; Vierucci A Curr Med Res Opin; 2006 Aug; 22(8):1515-22. PubMed ID: 16870076 [TBL] [Abstract][Full Text] [Related]
10. Tolerance of immunotherapy with a standardized extract of Alternaria tenuis in patients with rhinitis and bronchial asthma. Tabar AI; Lizaso MT; García BE; Echechipía S; Olaguibel JM; Rodríguez A J Investig Allergol Clin Immunol; 2000; 10(6):327-33. PubMed ID: 11206932 [TBL] [Abstract][Full Text] [Related]
11. Allergic rhinitis due to house dust mites: evaluation of the efficacy of specific sublingual immunotherapy. Tonnel AB; Scherpereel A; Douay B; Mellin B; Leprince D; Goldstein N; Delecluse P; Andre C Allergy; 2004 May; 59(5):491-7. PubMed ID: 15080829 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the efficacy of subcutaneous and sublingual immunotherapy in mite-sensitive patients with rhinitis and asthma--a placebo controlled study. Mungan D; Misirligil Z; Gürbüz L Ann Allergy Asthma Immunol; 1999 May; 82(5):485-90. PubMed ID: 10353581 [TBL] [Abstract][Full Text] [Related]
13. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis]. Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490 [TBL] [Abstract][Full Text] [Related]
14. Dose dependence of immunological response to sublingual immunotherapy. Marcucci F; Sensi L; Di Cara G; Incorvaia C; Frati F Allergy; 2005 Jul; 60(7):952-6. PubMed ID: 15932387 [TBL] [Abstract][Full Text] [Related]
15. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Valovirta E; Jacobsen L; Ljørring C; Koivikko A; Savolainen J Allergy; 2006 Oct; 61(10):1177-83. PubMed ID: 16942565 [TBL] [Abstract][Full Text] [Related]
16. Evaluation of immune parameters (including specific IgG4) during immunotherapy. Ruiz de León Loriga J; Lluch Pérez M; Valero Santiago A; Zamorano Calderón M; Huguet Casals J; Malet Casajuana A; García Calderón PA Allergol Immunopathol (Madr); 1989; 17(3):119-27. PubMed ID: 2479244 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of efficacy of immunotherapy in children with asthma monosensitized to Alternaria. Kiliç M; Altintaş DU; Yilmaz M; Bingöl-Karakoç G; Burgut R; Güneşer-Kendirli S Turk J Pediatr; 2011; 53(3):285-94. PubMed ID: 21980810 [TBL] [Abstract][Full Text] [Related]
18. Specific sublingual immunotherapy in atopic dermatitis. Results of a 6-year follow-up of 35 consecutive patients. Mastrandrea F; Serio G; Minelli M; Minardi A; Scarcia G; Coradduzza G; Parmiani S Allergol Immunopathol (Madr); 2000; 28(2):54-62. PubMed ID: 10804094 [TBL] [Abstract][Full Text] [Related]
19. A multicenter trial of specific local nasal immunotherapy. Motta G; Passali D; De Vincentiis I; Ottaviani A; Maurizi M; Sartoris A; Pallestrini E; Motta S; Salzano FA Laryngoscope; 2000 Jan; 110(1):132-9. PubMed ID: 10646729 [TBL] [Abstract][Full Text] [Related]
20. A role for measurement of nasal IgE antibodies in diagnosis of Alternaria-induced rhinitis in children. Fuiano N; Fusilli S; Incorvaia C Allergol Immunopathol (Madr); 2012; 40(2):71-4. PubMed ID: 21641712 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]